Editorial: "right place, wrong place": extravasation of therapeutic drug for molecular targeted radiotherapy.
Denardo
Gerald L
GL
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005119:Extravasation of Diagnostic and Therapeutic Materials; D006801:Humans; D000922:Immunotoxins / Q000009:adverse effects*; D015021:Yttrium Radioisotopes / Q000009:adverse effects*
D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D015021:Yttrium Radioisotopes; C422802:ibritumomab tiuxetan